after reconstitution, refrigerate at 28 C (35.646.4 F) and use within 24 weeks
Victoza is FDA-approved for the treatment of type 2 diabetes, while Saxenda is FDA-approved for the treatment of obesity
For women specifically, understanding how tirzepatide affects menstrual cycles is important, as hormonal shifts during rapid weight loss can alter cycle regularity
Some states include anti-obesity medications in their Medicaid formularies while others explicitly exclude them
If you want a broader look at how GLP-1 treatment fits into a personalized plan, read about GLP-1 support and how it can fit into a weight loss journey
The mean age of participants in this study was 63 years (SD 8, range 49-75), with a disease duration of 4.8 years (SD 2.9, range 1-13), and all had a disease severity from mild-moderate